Neuvasq’s most advanced programs are NVQ401, a first-in-class bispecific antibody that selectively activates the Wnt/β-catenin signaling cascade via Gpr124/Lrp6, and NVQ501, a fusion of a Gpr124/Lrp6 ...
Dive into The Register's online archive of incisive tech news reporting, features, and analysis dating back to 1998 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results